Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2008

Dec 3, 2008

6990_dirs_2008-12-03_78bd53ef-e46d-4b0f-a45b-a1cd10765e9b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2008-12-01

Reporting Person: Aberman Zami (Director, CEO & Co. Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-12-01 Common Stock A 138536 Acquired 138536 Direct

Footnotes

F1: The shares of common stock were issued to the reporting person in exchange for a voluntary reduction in the reporting
person's cash compensation (reflecting a value of $ 0.40 per share of common stock).